☰

Sanchari Bhattacharyya, Ph.D. - Publications

Affiliations: 
2011 Yeshiva University, New York, NY, United States 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ferri-Borgogno S, Barui S, McGee AM, Griffiths T, Singh PK, Piett CG, Ghosh B, Bhattacharyya S, Singhi A, Pradhan K, Verma A, Nagel Z, Maitra A, Gupta S. Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis. Cancers. 12. PMID 32967217 DOI: 10.3390/Cancers12092695  0.386
2019 Bhagat TD, Von Ahrens D, Dawlaty M, Zou Y, Baddour J, Achreja A, Zhao H, Yang L, Patel B, Kang C, Choudhary G, Gordon-Mitchell S, Aluri S, Bhattacharyya S, Sahu S, et al. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. 8. PMID 31663852 DOI: 10.7554/Elife.50663  0.424
2019 Jeong JJ, Gu X, Nie J, Sundaravel S, Liu H, Kuo WL, Bhagat TD, Pradhan K, Cao J, Nischal S, McGraw KL, Bhattacharyya S, Bishop MR, Artz A, Thirman MJ, et al. Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis. Cancer Discovery. PMID 31101629 DOI: 10.1158/2159-8290.CD-1-18  0.31
2019 Jeong JJ, Gu X, Nie J, Sundaravel S, Liu H, Kuo WL, Bhagat TD, Pradhan K, Cao J, Nischal S, McGraw KL, Bhattacharyya S, Bishop MR, Artz A, Thirman MJ, et al. Cytokine regulated phosphorylation and activation of TET2 by JAK2 in hematopoiesis. Cancer Discovery. PMID 30944118 DOI: 10.1158/2159-8290.Cd-18-1138  0.396
2019 Shenoy N, Bhagat TD, Cheville JC, Lohse C, Bhattacharyya S, Tischer A, Machha V, Gordon-Mitchell S, Choudhary GS, Wong LF, Gross L, Ressegue E, Leibovich BC, Boorjian SA, Steidl U, et al. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcystosine loss in renal cell carcinoma. The Journal of Clinical Investigation. PMID 30702441 DOI: 10.1172/Jci98747  0.381
2018 Shastri A, Choudhary G, Teixeira M, Gordon-Mitchell S, Ramachandra N, Bernard L, Bhattacharyya S, Lopez R, Pradhan K, Giricz O, Ravipati G, Wong LF, Cole S, Bhagat TD, Feld J, et al. Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells. The Journal of Clinical Investigation. PMID 30252677 DOI: 10.1172/Jci120156  0.422
2017 Bhattacharyya S, Pradhan K, Campbell N, Mazdo J, Vasantkumar A, Maqbool S, Bhagat TD, Gupta S, Suzuki M, Yu Y, Greally JM, Steidl U, Bradner J, Dawlaty M, Godley L, et al. Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways. Genome Research. PMID 28986391 DOI: 10.1101/Gr.222794.117  0.402
2016 Bachegowda L, Morrone K, Winski SL, Mantzaris I, Bartenstein M, Ramachandra N, Giricz O, Sukrithan V, Nwankwo G, Shahnaz S, Bhagat T, Bhattacharyya S, Assal A, Shastri A, Gordon-Mitchell S, et al. Pexmetinib: a novel dual inhibitor of Tie-2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid leukemia. Cancer Research. PMID 27287719 DOI: 10.1158/0008-5472.Can-15-3062  0.344
2016 Shastri A, Teixeira M, Bhattacharyya S, Ramachandra N, Lopez R, Ravipati G, Feld J, Dhar Y, Bhagat TD, Choudhary G, Giricz O, Bartenstein M, Sridharan A, Gordon-Mitchell S, Nawanko G, et al. Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3 Blood. 128: 4314-4314. DOI: 10.1182/Blood.V128.22.4314.4314  0.396
2015 Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, et al. TET1 is a tumor suppressor of hematopoietic malignancy. Nature Immunology. 16: 653-62. PMID 25867473 DOI: 10.1038/Ni.3148  0.389
2015 Schinke C, Giricz O, Li W, Shastri A, Gordon S, Barreryo L, Bhagat T, Bhattacharyya S, Ramachandra N, Bartenstein M, Pellagatti A, Boultwood J, Wickrema A, Yu Y, Will B, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 125: 3144-52. PMID 25810490 DOI: 10.1182/Blood-2015-01-621631  0.385
2015 Giricz O, Mo Y, Hu C, Dahlman K, Bhattacharyya S, Nguyen H, Matusow B, Bhagat T, Yu Y, Shellooe R, Burton E, Habets G, Greally J, Paraic K, Sosman J, et al. Abstract PR06: Integrated epigenomic profiling reveals widespread demethylation in melanoma and reveals CSF-1 Receptor as an aberrant regulator of malignant growth and invasion Cancer Research. 74: 4781-4781. DOI: 10.1158/1538-7445.Mel2014-Pr06  0.424
2014 Mariani CJ, Vasanthakumar A, Madzo J, Yesilkanal A, Bhagat T, Yu Y, Bhattacharyya S, Wenger RH, Cohn SL, Nanduri J, Verma A, Prabhakar NR, Godley LA. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma. Cell Reports. 7: 1343-52. PMID 24835990 DOI: 10.1016/J.Celrep.2014.04.040  0.339
2014 Bhagat TD, Zhou L, Sokol L, Mantzaris I, Bhattacharyya S, Gordon SAK, Yu Y, Gundabolu K, Nischal S, Polineni R, Schinke C, Chrysofakis G, Wickrema A, Pellagatti A, Boultwood J, et al. Abstract 5224: MicroRNA mediated regulation of TGF-β signaling leads to stem cell alterations in myelodysplastic syndromes Cancer Research. 74: 5224-5224. DOI: 10.1158/1538-7445.Am2014-5224  0.344
2014 Mo Y, Giricz O, Hu CH, Dahlman KB, Bhattacharyya S, Nguyen H, Matusow B, Bhagat T, Shellooe R, Burton E, Tsai J, Zhang C, Habets G, Shyr Y, Greally J, et al. Abstract 4781: Integrated epigenomic profiling reveals widespread demethylation in melanoma and reveals CSF-1 receptor as an aberrant regulator of malignant growth and invasion Molecular and Cellular Biology. DOI: 10.1158/1538-7445.Am2014-4781  0.328
2013 Yu Y, Mo Y, Ebenezer D, Bhattacharyya S, Liu H, Sundaravel S, Giricz O, Wontakal S, Cartier J, Caces B, Artz A, Nischal S, Bhagat T, Bathon K, Maqbool S, et al. High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis. The Journal of Biological Chemistry. 288: 8805-14. PMID 23306203 DOI: 10.1074/Jbc.M112.423756  0.412
2013 Mo Y, Giricz O, Hu C, Dahlman K, Bhattacharyya S, Nguyen H, Matusow B, Bhagat T, Yu Y, Shellooe R, Burton E, Habets G, Greally J, Kenny P, Sosman J, et al. Abstract A26: Integrated epigenomic profiling reveals widespread demethylation in melanoma, and reveals aberrant CSF-1 receptor expression as a regulator of malignant growth and invasion inhibited by PLX3397 Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A26  0.423
2013 Bhattacharyya S, Yu Y, Suzuki M, Cambpell N, Mazdo J, Vasantkumar A, Bhagat TD, Nischal S, Steidl U, Godley L, Maitra A, Greally JM, Verma A. Abstract 4231: Genome wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer. Cancer Research. 73: 4231-4231. DOI: 10.1158/1538-7445.Am2013-4231  0.36
2012 Will B, Zhou L, Vogler TO, Ben-Neriah S, Schinke C, Tamari R, Yu Y, Bhagat TD, Bhattacharyya S, Barreyro L, Heuck C, Mo Y, Parekh S, McMahon C, Pellagatti A, et al. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood. 120: 2076-86. PMID 22753872 DOI: 10.1182/Blood-2011-12-399683  0.352
2012 Shenoy N, Kessel R, Bhagat TD, Bhattacharyya S, Yu Y, McMahon C, Verma A. Alterations in the ribosomal machinery in cancer and hematologic disorders. Journal of Hematology & Oncology. 5: 32. PMID 22709827 DOI: 10.1186/1756-8722-5-32  0.321
2011 Bhattacharyya S, Tian J, Bouhassira EE, Locker J. Systematic targeted integration to study Albumin gene control elements. Plos One. 6: e23234. PMID 21858039 DOI: 10.1371/Journal.Pone.0023234  0.489
Show low-probability matches.